Fred Hutchinson Cancer Center: Prostatic Neoplasms trials
The registry lists 12 Prostatic Neoplasms studies with Fred Hutchinson Cancer Center as lead sponsor. 7 are open to participants now and 3 have results posted.
Phase 1 5Phase 2 5No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Testing Pasritamig Before Surgery for the Treatment of Localized Prostate CancerNot yet recruitingNCT07860255Phase 1
- IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07803653Phase 1
- Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP TrialRecruitingNCT07466498Phase 2
- Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT06236139Phase 1/2
- Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate CancerRecruitingNCT06145633Phase 2
- Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE TrialRecruitingNCT05918263Not applicable
- Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS StudyEnrolling by invitationNCT04254133
- Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerTerminatedNCT02454517Not applicableResults posted
- CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01881867Phase 2Results posted
- Effects of Sulforaphane on Normal Prostate TissueCompletedNCT00946309Phase 1/2Results posted
- Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate CancerWithdrawnNCT06094842Phase 1
- Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT StudyCompletedNCT04081779Not applicable